Stoke Therapeutics

Yahoo Finance • last year

SHAREHOLDER ALERT: Kaskela Law LLC Announces Investigation of Stoke Therapeutics, Inc. (NASDAQ: STOK) and Encourages Investors to Contact the Firm

PHILADELPHIA, Nov. 11, 2023 (GLOBE NEWSWIRE) -- Kaskela Law LLC announces that it is investigating Stoke Therapeutics, Inc. (NASDAQ: STOK) (“Stoke”) on behalf of the company’s investors. Since July 2023, shares of Stoke’s common stock h... Full story

Yahoo Finance • last year

Investor Alert: Abbott Cooper PLLC Announces Investigation into Stoke Therapeutics, Inc.; Urges Stoke Stockholders to Contact Abbott Cooper Regarding Their Legal Rights

STAMFORD, Conn., Nov. 04, 2023 (GLOBE NEWSWIRE) -- Abbott Cooper PLLC is investigating Stoke Therapeutics, Inc. (NASDAQ: STOK) (“Stoke” or the “Company”) on behalf of the Company’s investors. The subject of this investigation is to dete... Full story

Yahoo Finance • 2 years ago

Stoke Therapeutics Receives Authorization to Initiate a Phase 1/2 Study of STK-002 for Autosomal Dominant Optic Atrophy (ADOA) in the United Kingdom

– Company advancing second TANGO ASO into the clinic – – STK-002 has the potential to be the first disease-modifying therapy to address the root cause of ADOA, the most common inherited optic nerve disorder – BEDFORD, Mass., April 25, 20... Full story